UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

From the medical to the social prescription: A fashion, a formal procedure, or are we going to think about it a little?

Semergen, medicina de familia, 2018-10, Vol.44 (7), p.447-448

2018

Volltextzugriff (PDF)

Cloning and gene defects in microsomal triglyceride transfer protein associated with abetalipoproteinaemia

Nature (London), 1993-09, Vol.365 (6441), p.65-69

1993

Volltextzugriff (PDF)

Cardiovascular and metabolic risk in outpatients with schizoaffective disorder treated with antipsychotics: Results from the CLAMORS study

European psychiatry, 2012-05, Vol.27 (4), p.267-274

2012

Volltextzugriff (PDF)

A 1.2V 56mW 10 bit 165Ms/s pipeline-ADC for HD-video applications

ESSCIRC 2008 - 34th European Solid-State Circuits Conference, 2008, p.270-273

2008

Volltextzugriff (PDF)

A 1.2 V 4.5 mW 10 bit 8 MS/s cyclic-ADC for mobile video and sensor applications

Elektrotechnik und Informationstechnik, 2009-11, Vol.126 (11), p.396-402

2009

Volltextzugriff (PDF)

A 40mW pseudo-differential 200MHz analog video pre-processing for HDTV flat-panel displays

2009 16th IEEE International Conference on Electronics, Circuits and Systems - (ICECS 2009), 2009, p.611-614

2009

Volltextzugriff (PDF)

Quality of life in family caregivers of schizophrenia patients in Spain: caregiver characteristics, caregiving burden, family functioning, and social and professional support

International journal of psychiatry in clinical practice, 2018-01, Vol.22 (1), p.25-33

2018

Volltextzugriff (PDF)

Porcine pancreatic phospholipase A 2 isoforms: differential regulation by heparin

Biochimica et biophysica acta. Lipids and lipid metabolism, 1991, Vol.1082 (1), p.85-93

1991

Volltextzugriff (PDF)

BIM upregulation and ROS-dependent necroptosis mediate the antitumor effects of the HDACi Givinostat and Sorafenib in Hodgkin lymphoma cell line xenografts

Leukemia, 2014-09, Vol.28 (9), p.1861-1871

2014

Volltextzugriff (PDF)

236 (PB224): Tazemetostat and doxorubicin combined treatment in patient-derived preclinical models of epithelioid sarcoma

European journal of cancer (1990), 2024-10, Vol.211, p.114754, Article 114754

2024

Volltextzugriff (PDF)

Sorafenib inhibits lymphoma xenografts by targeting MAPK/ERK and AKT pathways in tumor and vascular cells

PloS one, 2013-04, Vol.8 (4), p.e61603-e61603

2013

Volltextzugriff (PDF)

Perifosine and sorafenib combination induces mitochondrial cell death and antitumor effects in NOD/SCID mice with Hodgkin lymphoma cell line xenografts

Leukemia, 2013-08, Vol.27 (8), p.1677-1687

2013

Volltextzugriff (PDF)

Targeting COPZ1 in thyroid tumour cells

European journal of cancer (1990), 2016-07, Vol.61, p.S94-S94

2016

Volltextzugriff (PDF)

439 - Targeting COPZ1 in thyroid tumour cells

European journal of cancer (1990), 2016-07, Vol.61, p.S94-S94

2016

Volltextzugriff (PDF)

The anti-human leukocyte antigen-DR monoclonal antibody 1D09C3 activates the mitochondrial cell death pathway and exerts a potent antitumor activity in lymphoma-bearing nonobese diabetic/ severe combined immunodeficient mice

Cancer research (Chicago, Ill.), 2006-02, Vol.66 (3), p.1799-1808

2006

Volltextzugriff (PDF)

174 Quantification of 3D Tumor Vessel Networks by Vessel Caliber, Amount and Distribution, Allows Comparison Among Effects of Vascular-targeted Therapies

European journal of cancer (1990), 2012-07, Vol.48, p.S42-S42

2012

Volltextzugriff (PDF)

960 Combining Vascular Disruption Activity of TRAIL-expressing CD34+ Cells With Antiangiogenic Activity of Sorafenib Improves Regression of Tumor Growth

European journal of cancer (1990), 2012-07, Vol.48, p.S231-S231

2012

Volltextzugriff (PDF)

Growth‐inhibitory effect of STI571 on cells transformed by the COL1A1/PDGFB rearrangement

International journal of cancer, 2001-05, Vol.92 (3), p.354-360

2001

Volltextzugriff (PDF)

Human CD34+ cells engineered to express membrane-bound tumor necrosis factor–related apoptosis-inducing ligand target both tumor cells and tumor vasculature

Blood, 2010-03, Vol.115 (11), p.2231-2240

2010

Volltextzugriff (PDF)

Characterization of compound 584, an Abl kinase inhibitor with lasting effects

Haematologica (Roma), 2008-05, Vol.93 (5), p.653-661

2008

Volltextzugriff (PDF)

The histone Deacetylase Inhibitor Givinostat in Combination with Sorafenib Induces Reactive Oxygen Species (ROS) Generation and Exerts Potent Antitumor Effects in NOD/SCID Mice with Hodgkin Lymphoma Cell Line Xenografts

Blood, 2012-11, Vol.120 (21), p.3711-3711

2012

Volltextzugriff (PDF)

Age- and irradiation-associated loss of bone marrow hematopoietic function in mice is reversed by recombinant human growth hormone

Experimental hematology, 2004-02, Vol.32 (2), p.171-178

2004

Volltextzugriff (PDF)

Induction of death receptor 5 expression in tumor vasculature by perifosine restores the vascular disruption activity of TRAIL-expressing CD34+ cells

Angiogenesis (London), 2013-07, Vol.16 (3), p.707-722

2013

Volltextzugriff (PDF)

Induction of death receptor 5 expression in tumor vasculature by perifosine restores the vascular disruption activity of TRAIL-expressing CD34^sup +^ cells

Angiogenesis (London), 2013-09, Vol.16 (3), p.707

2013

Volltextzugriff (PDF)

Preclinical Rationale for the Use of the Combined Treatment with the AKT Inhibitor Perifosine and the Multikinase Inhibitor Sorafenib in Hodgkin Lymphoma

Blood, 2011-11, Vol.118 (21), p.1653-1653

2011

Volltextzugriff (PDF)

1 – 25 von 51

Suche als RSS-Feed

Aktive Filter

ThemaBiochemistry & Molecular Biology

SpracheEnglisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(47)

Publikationsform

Artikel
(49)
Tagungsberichte
(2)

Sprache

Spanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

From the medical to the social prescription: A fashion, a formal procedure, or are we going to think about it a little?

Cloning and gene defects in microsomal triglyceride transfer protein associated with abetalipoproteinaemia

Cardiovascular and metabolic risk in outpatients with schizoaffective disorder treated with antipsychotics: Results from the CLAMORS study

A 1.2V 56mW 10 bit 165Ms/s pipeline-ADC for HD-video applications

A 1.2 V 4.5 mW 10 bit 8 MS/s cyclic-ADC for mobile video and sensor applications

A 40mW pseudo-differential 200MHz analog video pre-processing for HDTV flat-panel displays

Quality of life in family caregivers of schizophrenia patients in Spain: caregiver characteristics, caregiving burden, family functioning, and social and professional support

Porcine pancreatic phospholipase A 2 isoforms: differential regulation by heparin

BIM upregulation and ROS-dependent necroptosis mediate the antitumor effects of the HDACi Givinostat and Sorafenib in Hodgkin lymphoma cell line xenografts

236 (PB224): Tazemetostat and doxorubicin combined treatment in patient-derived preclinical models of epithelioid sarcoma

Sorafenib inhibits lymphoma xenografts by targeting MAPK/ERK and AKT pathways in tumor and vascular cells

Perifosine and sorafenib combination induces mitochondrial cell death and antitumor effects in NOD/SCID mice with Hodgkin lymphoma cell line xenografts

Targeting COPZ1 in thyroid tumour cells

439 - Targeting COPZ1 in thyroid tumour cells

The anti-human leukocyte antigen-DR monoclonal antibody 1D09C3 activates the mitochondrial cell death pathway and exerts a potent antitumor activity in lymphoma-bearing nonobese diabetic/ severe combined immunodeficient mice

174 Quantification of 3D Tumor Vessel Networks by Vessel Caliber, Amount and Distribution, Allows Comparison Among Effects of Vascular-targeted Therapies

960 Combining Vascular Disruption Activity of TRAIL-expressing CD34+ Cells With Antiangiogenic Activity of Sorafenib Improves Regression of Tumor Growth

Growth‐inhibitory effect of STI571 on cells transformed by the COL1A1/PDGFB rearrangement

Human CD34+ cells engineered to express membrane-bound tumor necrosis factor–related apoptosis-inducing ligand target both tumor cells and tumor vasculature

Characterization of compound 584, an Abl kinase inhibitor with lasting effects

The histone Deacetylase Inhibitor Givinostat in Combination with Sorafenib Induces Reactive Oxygen Species (ROS) Generation and Exerts Potent Antitumor Effects in NOD/SCID Mice with Hodgkin Lymphoma Cell Line Xenografts

Age- and irradiation-associated loss of bone marrow hematopoietic function in mice is reversed by recombinant human growth hormone

Induction of death receptor 5 expression in tumor vasculature by perifosine restores the vascular disruption activity of TRAIL-expressing CD34+ cells

Induction of death receptor 5 expression in tumor vasculature by perifosine restores the vascular disruption activity of TRAIL-expressing CD34^sup +^ cells

Preclinical Rationale for the Use of the Combined Treatment with the AKT Inhibitor Perifosine and the Multikinase Inhibitor Sorafenib in Hodgkin Lymphoma

Aktive Filter

Suchergebnisse filtern